NCT05213468

Brief Summary

The investigators aim to validate if a digital tool for increased self-management of chronic pain can improve the quality of life for patients with chronic pain. The validation is based on the change in pain interference (Quality of life), pain intensity, physical functioning, depression, and anxiety based on self-reported information from baseline to study end.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable chronic-pain

Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 5, 2022

Completed
23 days until next milestone

First Posted

Study publicly available on registry

January 28, 2022

Completed
4 days until next milestone

Study Start

First participant enrolled

February 1, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2023

Completed
Last Updated

June 15, 2023

Status Verified

June 1, 2023

Enrollment Period

1.2 years

First QC Date

January 5, 2022

Last Update Submit

June 12, 2023

Conditions

Keywords

self managemente-healthhealth techDigital Pain-Management Tool

Outcome Measures

Primary Outcomes (1)

  • Pain interference

    Change from baseline in pain interference (QoL), measured by PROMIS Pain Interference 4a . Measure of the amount of interference pain causes in life; range 4-20; higher is worse

    6 and 12 weeks from baseline

Secondary Outcomes (7)

  • Pain severity

    6 and 12 weeks from baseline

  • Physical function

    6 and 12 weeks from baseline

  • Depression

    6 and 12 weeks from baseline

  • Anxiety

    6 and 12 weeks from baseline

  • Fatigue

    6 and 12 weeks from baseline

  • +2 more secondary outcomes

Study Arms (2)

Self management app as add on to standard care

EXPERIMENTAL

PainDrainerTM App as add on to standard treatment at the physiotherapy program at the clinic PainDrainer software application: PainDrainerTM app (version 1.1.19c). ' The PainDrainer app is an investigational device, intended as a digital aid for the self-management of chronic pain for use by adults without supervision by healthcare professionals in a home setting.

Device: PainDrainerTM

Standard of care

NO INTERVENTION

Treatment as usual, standard treatment of care at the physiotherapy program at the clinic

Interventions

Self management digital tool for chronic pain

Self management app as add on to standard care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Have a pain condition that requires analysis and rehabilitation at a specialist clinic
  • \>18 years of age
  • Be medically investigated, with adequate pharmacological treatment, and do not have any other medical examination or ongoing illness that hinders participation in the physiotherapy program at VO Neurosurgery and Pain rehabilitation, Skåne University Hospital, Lund
  • Being included in the physiotherapy program, at VO Neurosurgery and Pain rehabilitation, Skåne University Hospital, Lund
  • Have the knowledge and proficiency to use a smart phone, tablet or computer

You may not qualify if:

  • Severe or acute psychiatric illness, severe anxiety or depression

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VO Neurokirurgi och Smärtrehabilitering Skånes universitetssjukhus

Lund, 21428, Sweden

Location

MeSH Terms

Conditions

Chronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Marcelo Rivano Fischer, Clin.Psy.D

    VO Neurosurgery and Pain rehabilitation, Skåne University Hospital, Lund

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Masking Details
Parallel study, single blinded
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Parallel study, single blinded
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 5, 2022

First Posted

January 28, 2022

Study Start

February 1, 2022

Primary Completion

April 1, 2023

Study Completion

April 1, 2023

Last Updated

June 15, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations